Therefore, these two types of insulin pumps, using the same basal and bolus insulin doses, have the same clinical efficacy in the management of hyperglycemia, control of postprandial glucose excursion, and risk of hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.